Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology
ACS Medicinal Chemistry Letters – May 08, 2024
Source: OpenAlex
Summary
Psychedelics are entering a new era of therapeutic application, with innovations in pharmacology offering precise control. Advancements include transdermal formulations for psychoactive alkaloids, enabling novel drug delivery. Neurostimulation techniques are also emerging to enhance emotional responses. Psilocybin, a potent hallucinogen, is being explored via intravenous infusion for medicine. This progress in drug studies also involves the chemical synthesis of crystalline tryptamine derivatives, impacting neurotransmitter receptor influence on behavior. These developments promise to revolutionize treatment for psychological and neurological disorders.
Abstract
This Patent Highlight explores advancements in pharmacology, focusing on the novel delivery and application of psychoactive substances. It highlights the development of transdermal formulations for psychoactive alkaloids, neuroenhancement techniques to augment emotional responses, and the intravenous infusion of psilocybin or psilocin for various therapeutic purposes. Additionally, it delves into the characterization and potential uses of crystalline forms of tryptamine derivatives. These innovations signify significant progress in drug delivery systems, neurostimulation methods, and the therapeutic use of psychedelic compounds, potentially revolutionizing the treatment of psychological and neurological disorders.